author-photo

Stacy L. Moulder

University of Texas MD Anderson Cancer Center

59

Papers

352

Citations

Citation Trend

Filter By

Papers (45) Sort By

Journal Conference Others

Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PD6-07: Volumetric changes on longitudinal dynamic contrast enhanced MR imaging (DCE-MRI) as an early treatment response predictor to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD6-06: Radiomic phenotypes from dynamic contrast-enhanced MRI (DCE-MRI) parametric maps for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS7-12: Impact of race/ethnicity on triple negative breast cancer molecular features, treatment response and clinical outcomes in patients receiving neoadjuvant therapy

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Abstract PS3-08: Assessment of early response to neoadjuvant systemic therapy (NAST) of triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: A pilot study

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Neoadjuvant atezolizumab (atezo) and nab-paclitaxel (nab-p) in patients (pts) with triple-negative breast cancer (TNBC) with suboptimal clinical response to doxorubicin and cyclophosphamide (AC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS18-04: Prospective evaluation of patients with metaplastic (Mp) triple negative breast cancer (TNBC): Molecular characteristics and outcomes with neoadjuvant therapy (NAT)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD9-05: A tiered algorithm using mid-therapy ultrasound (US) response assessment and a novel gene expression signature (GES) improves the prediction of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in triple-negative breast cancer (TNBC): Results from the ARTEMIS trial (NCT02276443)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)